Ford and General Motors have navigated choppy waters amid an unpredictable year, but both were just dealt another blow to the ...

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today a revised full year outlook for 2025 in response to recent ...

BDC stocks trade at a steep 22% NAV discount, reflecting broad investor fear, but this may be a contrarian opportunity. Read why it’s time to be greedy.

UAE corporate tax dictates that the rules of International Financial Reporting Standards must be applied when calculating ...

CLPS Incorporation (the 'Company' or 'CLPS') (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025.

Strategic thesis: why Solana-based DATs, such as DeFi Development Corp. (DFDV), may deliver asymmetric upside as the market re-prices risk and network leadership.

The Drug Testing Systems market is witnessing diverse growth trajectories across global regions. China leads the charge with ...

During the third quarter of 2025, Fifth Third repurchased $300 million of its common stock, which reduced shares outstanding by approximately 6.9 million at quarter end. Fifth Third increased its ...

CSX Corp. (NASDAQ: CSX) today announced third quarter operating income of $1.09 billion and net earnings of $694 million, or $0.37 per share. Excluding ...

Revenue in the third quarter 2025 is expected to be positively impacted by unaudited provisional pricing adjustments on prior ...

Following the re-election of President Donald Trump, recent policy changes in the United States have increased volatility in ...

Kezar Life Sciences, Inc. (Nasdaq: KZR, the Company), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today ...